Stocks of Hims & Hers Health Inc (NYSE:HIMS) traded higher last session on Wall Street, up 4.68% to $34.69.
HIMS stock price is now -8.58% away from the 50-day moving average and 35.78% away from the 200-day moving average. The market capitalization of the company currently stands at $7.71B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target enhanced from $42 to $60, Morgan Stanley Downgraded its rating from Overweight to Equal-Weight for Hims & Hers Health Inc (NYSE: HIMS). On January 10, 2025, Citigroup Downgraded its previous ‘Neutral’ rating to ‘Sell’ on the stock increasing its target price from $24 to quote $25, while ‘BTIG Research’ rates the stock as ‘Buy’
In other news, Dudum Andrew, Officer bought 175,661 shares of the company’s stock on Mar 17 ’25. The stock was bought for $5,952,296 at an average price of $33.89. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 11 ’25, PAO Becklund Irene sold 2,203 shares of the business’s stock. A total of $76,598 was realized by selling the stock at an average price of $34.77. This leaves the insider owning 2,203 shares of the company worth $76422.07. A total of 18.06% of the company’s stock is owned by insiders.
During the past 12 months, Hims & Hers Health Inc has had a low of $11.20 and a high of $72.98. As of last week, the company has a debt-to-equity ratio of 0.02, a current ratio of 1.79, and a quick ratio of 1.50. According to the stock market information, the enterprise value for the company is $7418017792, which is based on a 64.87 price-to-earnings ratio, a 2.09 price-to-earnings-growth ratio, and a beta of 1.61. The fifty day moving average price for HIMS is $37.9476 and a two-hundred day moving average price translates $25.54805 for the stock.
The latest earnings results from Hims & Hers Health Inc (NYSE: HIMS) was released for 2024-12-31. The net profit margin was 8.54% and return on equity was 30.71% for HIMS. The company reported revenue of $481.14 million for the quarter, compared to $246.62 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 95.09 percent.
